Edition:
United States

Vanda Pharmaceuticals Inc accepts Fanaptum Marketing authorization application for treatment of Schizophrenia in adults


Tuesday, 22 Dec 2015 04:30pm EST 

Vanda Pharmaceuticals Inc:Says Marketing Authorization Application for oral Fanaptum tablets has been accepted for evaluation by European Medicines Agency for treatment of schizophrenia in adults.